Should I buy or sell 22nd Century Group stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for 22nd Century Group in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" XXII shares. View XXII analyst ratings or view top-rated stocks .

What is 22nd Century Group's stock price target for 2024?

4 Wall Street research analysts have issued 1 year target prices for 22nd Century Group's shares. Their XXII share price targets range from $5.00 to $45.00. On average, they anticipate the company's stock price to reach $19.17 in the next twelve months. This suggests a possible upside of 8,233.3% from the stock's current price. View analysts price targets for XXII or view top-rated stocks among Wall Street analysts .

How have XXII shares performed in 2023?

22nd Century Group's stock was trading at $13.8075 at the start of the year. Since then, XXII shares have decreased by 98.3% and is now trading at $0.23. View the best growth stocks for 2023 here .

Are investors shorting 22nd Century Group?

22nd Century Group saw a drop in short interest in November. As of November 15th, there was short interest totaling 1,490,000 shares, a drop of 19.5% from the October 31st total of 1,850,000 shares. Based on an average daily volume of 717,200 shares, the short-interest ratio is currently 2.1 days. Currently, 4.9% of the company's shares are short sold. View 22nd Century Group's Short Interest .

When is 22nd Century Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 14th 2024. View our XXII earnings forecast .

How were 22nd Century Group's earnings last quarter?

22nd Century Group, Inc. (NASDAQ:XXII) posted its quarterly earnings data on Monday, November, 6th. The biotechnology company reported ($0.78) earnings per share for the quarter, topping the consensus estimate of ($0.91) by $0.13. The biotechnology company earned $17.81 million during the quarter, compared to analyst estimates of $20.06 million. 22nd Century Group had a negative net margin of 167.13% and a negative trailing twelve-month return on equity of 121.41%.

What ETF holds 22nd Century Group's stock ?

ETFMG Alternative Harvest ETF holds 55,201 shares of XXII stock, representing 0.08% of its portfolio.

When did 22nd Century Group's stock split?

22nd Century Group's stock reverse split on the morning of Wednesday, July 5th 2023. The 1-15 reverse split was announced on Wednesday, July 5th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 5th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What other stocks do shareholders of 22nd Century Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 22nd Century Group investors own include Aurora Cannabis (ACB) , Alteryx (AYX) , Auxly Cannabis Group (CBWTF) , Charlotte's Web (CWBHF) , Enphase Energy (ENPH) , Inseego (INSG) , Luckin Coffee (LKNCY) , MediPharm Labs (MEDIF) and MercadoLibre (MELI) .

Who are 22nd Century Group's major shareholders?

22nd Century Group's stock is owned by many different retail and institutional investors. Top institutional investors include HighTower Advisors LLC (0.37%), Mercer Global Advisors Inc. ADV (0.24%), Walleye Capital LLC (0.00%), TRUE Private Wealth Advisors (0.10%), Cutler Group LLC CA (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Clifford B Fleet, James A Mish , John Franzino, Michael Zercher and Roger D O'brien. View institutional ownership trends .

How do I buy shares of 22nd Century Group?

Shares of XXII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

22nd Century Group (XXII) Stock Price, News & Analysis

$0.23

-0.01 (-4.13%)

(As of 12/8/2023 08:58 PM ET)

Compare

Today's Range: $0.21
▼
$0.23
50-Day Range: $0.21
▼
$0.88
52-Week Range: $0.20
▼
$18.98

Volume: 1.06 million shs
Average Volume: 688,991 shs
Market Capitalization: $7.10 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $19.17

22nd Century Group MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 8,233.3% Upside
$19.17 Price Target
Short Interest: Healthy
4.90% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.93
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($4.30) to ($0.95) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.28 out of 5 stars

3.3

Analyst's Opinion

Consensus Rating
22nd Century Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $19.17, 22nd Century Group has a forecasted upside of 8,233.3% from its current price of $0.23.
Amount of Analyst Coverage
22nd Century Group has received no research coverage in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
4.90% of the float of 22nd Century Group has been sold short.
Short Interest Ratio / Days to Cover
22nd Century Group has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in 22nd Century Group has recently decreased by 19.46%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
22nd Century Group does not currently pay a dividend.
Dividend Growth
22nd Century Group does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for XXII.

3.3

News and Social Media Coverage

News Sentiment
22nd Century Group has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Consumer Staples companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for 22nd Century Group this week, compared to 2 articles on an average week.
Search Interest
Only 2 people have searched for XXII on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
MarketBeat Follows
7 people have added 22nd Century Group to their MarketBeat watchlist in the last 30 days. This is an increase of 75% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, 22nd Century Group insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.60% of the stock of 22nd Century Group is held by insiders.

1.3

Earnings and Valuation

Earnings Growth
Earnings for 22nd Century Group are expected to grow in the coming year, from ($4.30) to ($0.95) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of 22nd Century Group is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of 22nd Century Group is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
22nd Century Group has a P/B Ratio of 0.03. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About 22nd Century Group Stock (NASDAQ:XXII)

22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.

XXII Stock Price History

30 days | 90 days | 365 days | Advanced Chart

XXII Stock News Headlines

December 11, 2023 | americanbankingnews.com

22nd Century Group (NASDAQ:XXII) vs. Japan Tobacco (OTCMKTS:JAPAF) Head-To-Head Analysis

December 7, 2023 | markets.businessinsider.com

Optimistic Outlook: Buy Rating on 22nd Century Group Amidst Leadership Change and Strategic Shift

December 11, 2023 | Autonomix (Ad)

How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology

Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

December 4, 2023 | finance.yahoo.com

22nd Century Secures $3.2 Million to Date in Warrant Exchange Transaction

December 1, 2023 | americanbankingnews.com

22nd Century Group, Inc. (NASDAQ:XXII) Short Interest Update

November 29, 2023 | finanznachrichten.de

22nd Century Group, Inc: 22nd Century Appoints Larry Firestone as Chairman and CEO

November 29, 2023 | markets.businessinsider.com

22nd Century Appoints Larry Firestone As Chairman, CEO

November 29, 2023 | finance.yahoo.com

22nd Century Appoints Larry Firestone as Chairman and CEO

December 11, 2023 | Autonomix (Ad)

How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology

November 28, 2023 | msn.com

22nd Century Group Offloads Hemp/Cannabis Franchise In $2.25M Deal, Seeks To 'Reduce Cash And Operating Demands'

November 28, 2023 | finanznachrichten.de

22nd Century Group, Inc: 22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchise

November 27, 2023 | msn.com

22nd Century to sell its hemp/cannabis franchise, stock jumps ~13% after hours

November 27, 2023 | msn.com

22nd Century Group (XXII) Price Target Increased by 30.94% to 41.93

November 27, 2023 | finance.yahoo.com

22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchise

November 24, 2023 | realmoney.thestreet.com

This Stock Is Not Having Its Moment of the 'Century'

November 24, 2023 | finance.yahoo.com

These Analysts Just Made A Substantial Downgrade To Their 22nd Century Group, Inc. (NASDAQ:XXII) EPS Forecasts

November 21, 2023 | marketwatch.com

22nd Century Group's Stock Slides After Analyst Pulls Price Target

November 8, 2023 | finance.yahoo.com

22nd Century Group Continues VLN® Expansion, Now Retailing in More Than 5,100 Stores

November 7, 2023 | finance.yahoo.com

22nd Century Group (XXII) Expands Reduced Nicotine Content Tobacco IP with Latest Technology License

November 6, 2023 | bizjournals.com

22nd Century loses $73M in 3rd quarter

November 6, 2023 | finance.yahoo.com

22nd Century Group (XXII) Reports Third Quarter 2023 Financial Results

November 6, 2023 | finance.yahoo.com

22nd Century Group Inc (XXII) Reports Q3 2023 Financial Results: Net Loss Widens Amid Expansion ...

October 26, 2023 | finance.yahoo.com

22nd Century Group (XXII) Supports FDA Policy Advancements, Proposed Menthol Ban Now at OMB

October 25, 2023 | finance.yahoo.com

22nd Century Group (XXII) Reduces Debt by $8.1 Million

October 17, 2023 | marketwatch.com

22nd Century Group Shares Fall 13% After Share Sale Priced

October 17, 2023 | msn.com

22nd Century Group prices public offering to raise $5.25M

October 17, 2023 | finance.yahoo.com

22nd Century Announces Pricing of $5.25 Million Public Offering

See More Headlines

Receive XXII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 22nd Century Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/06/2023
Today: 12/11/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 3/14/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Cigarettes
Sub-Industry: Cannabis
Sector: Consumer Staples
Current Symbol: NASDAQ:XXII
Previous Symbol: AMEX:XXII
CUSIP: N/A
CIK: 1347858
Web: www.xxiicentury.com
Phone: (716) 270-1523
Fax: 716-877-3064
Employees: 198
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $19.17
High Stock Price Target: $45.00
Low Stock Price Target: $5.00
Potential Upside/Downside: +8,233.3%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($8.0785)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-59,800,000.00
Net Margins: -167.13%
Pretax Margin: -164.47%
Return on Equity: -121.41%
Return on Assets: -74.82%

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 1.02
Quick Ratio: 0.62

Sales & Book Value

Annual Sales: $62.11 million
Price / Sales: 0.11
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $6.68 per share
Price / Book: 0.03

Miscellaneous

Outstanding Shares: 30,880,000
Free Float: 30,693,000
Market Cap: $7.10 million
Optionable: Optionable
Beta: 1.58

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for December 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Mr. James A. Mish (Age 59)
Corporate President, Member of Scientific Advisory Board & Director
Comp: $985.11k
Mr. R. Hugh Kinsman
Chief Financial Officer
Mr. John J. Miller (Age 58)
COO & Executive Officer
Comp: $596.38k
Mr. Lawrence D. Firestone (Age 65)
Chairman & CEO
Mr. Peter F. Ferola (Age 54)
Chief Legal Officer & Corporate Secretary
Mr. Sebastian Ravitz
Vice President of Marketing
Matthew Kreps
Investor Relations
Mr. James C. Morrison
Technical Advisor & Regulatory Affairs Consultant

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

XXII Stock Analysis - Frequently Asked Questions

Should I buy or sell 22nd Century Group stock right now?: 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for 22nd Century Group in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" XXII shares.
View XXII analyst ratings or view top-rated stocks.
What is 22nd Century Group's stock price target for 2024?: 4 Wall Street research analysts have issued 1 year target prices for 22nd Century Group's shares. Their XXII share price targets range from $5.00 to $45.00. On average, they anticipate the company's stock price to reach $19.17 in the next twelve months. This suggests a possible upside of 8,233.3% from the stock's current price.
View analysts price targets for XXII or view top-rated stocks among Wall Street analysts.
How have XXII shares performed in 2023?: 22nd Century Group's stock was trading at $13.8075 at the start of the year. Since then, XXII shares have decreased by 98.3% and is now trading at $0.23.
View the best growth stocks for 2023 here.
Are investors shorting 22nd Century Group?: 22nd Century Group saw a drop in short interest in November. As of November 15th, there was short interest totaling 1,490,000 shares, a drop of 19.5% from the October 31st total of 1,850,000 shares. Based on an average daily volume of 717,200 shares, the short-interest ratio is currently 2.1 days. Currently, 4.9% of the company's shares are short sold.
View 22nd Century Group's Short Interest.
When is 22nd Century Group's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, March 14th 2024.
View our XXII earnings forecast.
How were 22nd Century Group's earnings last quarter?: 22nd Century Group, Inc. (NASDAQ:XXII) posted its quarterly earnings data on Monday, November, 6th. The biotechnology company reported ($0.78) earnings per share for the quarter, topping the consensus estimate of ($0.91) by $0.13. The biotechnology company earned $17.81 million during the quarter, compared to analyst estimates of $20.06 million. 22nd Century Group had a negative net margin of 167.13% and a negative trailing twelve-month return on equity of 121.41%.

What ETF holds 22nd Century Group's stock ?: ETFMG Alternative Harvest ETF holds 55,201 shares of XXII stock, representing 0.08% of its portfolio.
When did 22nd Century Group's stock split?: 22nd Century Group's stock reverse split on the morning of Wednesday, July 5th 2023. The 1-15 reverse split was announced on Wednesday, July 5th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 5th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.
What other stocks do shareholders of 22nd Century Group own?: Based on aggregate information from My MarketBeat watchlists, some companies that other 22nd Century Group investors own include Aurora Cannabis (ACB), Alteryx (AYX), Auxly Cannabis Group (CBWTF), Charlotte's Web (CWBHF), Enphase Energy (ENPH), Inseego (INSG), Luckin Coffee (LKNCY), MediPharm Labs (MEDIF) and MercadoLibre (MELI).
Who are 22nd Century Group's major shareholders?: 22nd Century Group's stock is owned by many different retail and institutional investors. Top institutional investors include HighTower Advisors LLC (0.37%), Mercer Global Advisors Inc. ADV (0.24%), Walleye Capital LLC (0.00%), TRUE Private Wealth Advisors (0.10%), Cutler Group LLC CA (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Clifford B Fleet, James A Mish, John Franzino, Michael Zercher and Roger D O'brien.
View institutional ownership trends.
How do I buy shares of 22nd Century Group?: Shares of XXII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:XXII) was last updated on 12/11/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial